Arkolith/Insider Trading/NTLA/Form 4

Clark Eliana

EVP, Chief Technical OfficerIntellia Therapeutics, Inc. (NTLA) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)607$13.78$8K94K
Mar 1, 2026Grant(A)7K—$094K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2026Grant(A)11K—$011K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-088241) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML